2019 SCAI SHOCK

Part 3: Special Clinical Scenarios and the Future, Group A

Case: Double Indication for Impella CP—High-Risk PCI and Acute MI Complicated by Cardiogenic Shock
Rodrigo V. Wainstein, M.D., Ph.D., Hospital de Clinicas de Porto Alegre, Porto Alegre, ON, Brazil
Cardiogenic Shock Algorithm From Inova Heart and Vascular Institute
Behnam N. Tehrani, M.D., Inova Heart and Vascular Institute, Oakton, VA
National Cardiogenic Shock Initiative
William W. O'Neill, MD, MSCAI, Henry Ford Health System, Detroit, MI
SHOCK Trials Overview
Mauricio G. Cohen, M.D., FSCAI, University Of Miami Miller School Of Medicine, Pinecrest, FL
The Future of Shock Studies
Navin K. Kapur, M.D., FSCAI, Tufts Medical Center, Boston, MA
Management of Cardiac Arrest
Demetri Yannopoulos, M.D., FSCAI, University of Minnesota, Minnesapolis, MN
Challenging Access
Khaldoon Alaswad, M.D., FSCAI, Henry Ford Hospital, Detroit, MI
Shock Patients: Managing Bleeding
James M. McCabe, MD, FSCAI, The University of Washington, Seattle, WA
See more of: SCAI SHOCK